Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells | Scientific Reports
Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties
Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives | Cell Physiol Biochem
Proteomic and Phosphoproteomic Analyses Reveal the Oncogenic Role of PTK7-NDRG1 Axis in Non-small-cell Lung Cancer Cell Resistance to AZD9291 | ACS Chemical Biology
PTEN/MMAC1 mutations found in lung cancers | Download Table
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR - Ariyasu - 2021 - Cancer Science - Wiley Online Library
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling | Cell Death & Disease
Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations | medRxiv
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis - Liu - 2020 - Cancer Communications - Wiley Online Library
pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma | Communications Biology
Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing - ScienceDirect
SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer | Nature Communications
Clinical Implication of MicroRNA for Lung Cancer | Cancer Biotherapy and Radiopharmaceuticals
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer | Molecular Medicine | Full Text
Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation | Oncogene
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
Lung Cancer - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
![PDF] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0cf466fd259f6bee54109793ae154a69035d609c/7-Table4-1.png "PDF] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations | Semantic Scholar")
PDF] Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations | Semantic Scholar
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
Novel serum biomarkers for lung cancer early diagnosis and clinical outcome
Lung Cancer | Basicmedical Key
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer | SpringerLink
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells - ScienceDirect
